D. Xie, Z. Li / Tetrahedron xxx (2018) 1e9
7
J ¼ 7.7 Hz, 1H), 6.37 (d, J ¼ 7.8 Hz, 1H). 13C NMR (150 MHz, DMSO‑d6)
4.2.15. (Z)-2-(2-bromophenyl)-2-(2-oxoindolin-3-ylidene)
acetonitrile (3o)
d
165.35, 159.07 (d, J ¼ 247.6 Hz), 144.51, 141.01, 134.28, 133.74 (d,
J ¼ 8.3 Hz), 131.23, 126.35 (d, J ¼ 3.3 Hz), 124.65, 122.34, 120.49 (d,
J ¼ 15.0 Hz), 120.21, 117.26 (d, J ¼ 20.5 Hz), 116.64, 111.30, 107.64.
Anal. Calcd. For C16H9FN2O: C, 72.72; H, 3.43; N, 10.60. Found: C,
72.67; H, 3.44; N, 10.65.
Orange red solid; mp 171e173 ꢁC; 1H NMR (600 MHz, DMSO‑d6)
11.03 (s, 1H), 7.90 (dd, J ¼ 8.1, 1.2 Hz, 1H), 7.65 (dd, J ¼ 7.6, 1.8 Hz,
d
1H), 7.61 (td, J ¼ 7.5, 1.2 Hz, 1H), 7.54 (td, J ¼ 7.7, 1.7 Hz, 1H), 7.28 (td,
J ¼ 7.7,1.2 Hz,1H), 6.85 (d, J ¼ 7.9 Hz,1H), 6.69 (td, J ¼ 7.7,1.0 Hz,1H),
5.99 (d, J ¼ 7.6 Hz, 1H). 13C NMR (150 MHz, DMSO‑d6)
d 165.40,
144.40, 140.51, 134.18, 134.12, 133.43, 132.84, 130.97, 129.79, 124.89,
122.43, 121.80, 120.26, 116.13, 113.01, 111.31. Anal. Calcd. For
4.2.10. (Z)-2-(3-fluorophenyl)-2-(2-oxoindolin-3-ylidene)
acetonitrile (3j)
C16H9BrN2O: C, 59.10; H, 2.79; N, 8.62. Found: C, 59.16; H, 2.80; N,
Orange red solid; mp 226e228 ꢁC; 1H NMR (600 MHz, DMSO‑d6)
8.58.
d
10.97 (s, 1H), 7.67e7.62 (m, 1H), 7.53 (dt, J ¼ 9.4, 2.1 Hz, 1H),
7.48e7.41 (m, 2H), 7.28 (td, J ¼ 7.8, 1.2 Hz, 1H), 6.84 (d, J ¼ 7.8 Hz,
4.2.16. (Z)-2-(3-bromophenyl)-2-(2-oxoindolin-3-ylidene)
acetonitrile (3p)
1H), 6.73 (t, J ¼ 7.7 Hz, 1H), 6.48 (d, J ¼ 8.1 Hz, 1H). 13C NMR
(150 MHz, DMSO‑d6)
d
165.67, 162.86 (d, J ¼ 245.0 Hz), 144.39,
Orange red solid; mp 209e211 ꢁC; 1H NMR (600 MHz, DMSO‑d6)
139.70, 135.30 (d, J ¼ 8.1 Hz), 133.97, 132.46 (d, J ¼ 8.5 Hz), 125.22 (d,
J ¼ 2.9 Hz), 124.86, 122.14, 120.26, 118.01 (d, J ¼ 20.7 Hz), 117.31,
116.02 (d, J ¼ 22.8 Hz), 113.18 (d, J ¼ 2.3 Hz), 111.21. Anal. Calcd. For
d
10.97 (s, 1H), 7.86 (t, J ¼ 1.8 Hz, 1H), 7.79 (ddd, J ¼ 8.0, 2.1, 1.0 Hz,
1H), 7.63 (dt, J ¼ 7.8, 1.3 Hz, 1H), 7.54 (t, J ¼ 7.9 Hz, 1H), 7.28 (td,
J ¼ 7.7,1.2 Hz,1H), 6.84 (d, J ¼ 7.8 Hz,1H), 6.73 (td, J ¼ 7.7,1.0 Hz,1H),
C
16H9FN2O: C, 72.72; H, 3.43; N, 10.60. Found: C, 72.80; H, 3.40; N,
6.48 (d, J ¼ 7.8 Hz, 1H). 13C NMR (150 MHz, DMSO‑d6)
d 165.65,
10.57.
144.44, 139.76, 135.41, 134.00, 133.85, 132.27, 131.48, 128.13, 124.78,
123.00, 122.13, 120.29, 117.35, 113.00, 111.25. Anal. Calcd. For
C
8.65.
16H9BrN2O: C, 59.10; H, 2.79; N, 8.62. Found: C, 59.01; H, 2.81; N,
4.2.11. (Z)-2-(4-fluorophenyl)-2-(2-oxoindolin-3-ylidene)
acetonitrile (3k)
Orange red solid; mp 259e261 ꢁC; 1H NMR (600 MHz, DMSO‑d6)
4.2.17. (Z)-2-(4-bromophenyl)-2-(2-oxoindolin-3-ylidene)
acetonitrile (3q)
d
10.95 (s, 1H), 7.69 (dd, J ¼ 8.6, 5.4 Hz, 2H), 7.43 (t, J ¼ 8.8 Hz, 2H),
7.27 (t, J ¼ 8.4 Hz, 1H), 6.84 (d, J ¼ 7.8 Hz, 1H), 6.73 (t, J ¼ 7.7 Hz, 1H),
Orange red solid; mp 267e269 ꢁC; 1H NMR (600 MHz, DMSO‑d6)
10.95 (s, 1H), 7.80 (dd, J ¼ 8.4, 2.1 Hz, 2H), 7.59 (dd, J ¼ 8.5, 2.1 Hz,
6.55 (d, J ¼ 7.8 Hz, 1H). 13C NMR (150 MHz, DMSO‑d6)
d 165.75,
d
163.54 (d, J ¼ 247.2 Hz), 144.26, 139.25, 133.79, 131.64 (d, J ¼ 8.7 Hz),
129.57 (d, J ¼ 3.0 Hz), 124.74, 122.10, 120.39, 117.62, 117.27 (d,
J ¼ 22.2 Hz), 113.85, 111.15. Anal. Calcd. For C16H9FN2O: C, 72.72; H,
3.43; N, 10.60. Found: C, 72.68; H, 3.45; N, 10.56.
2H), 7.29 (t, J ¼ 7.8 Hz, 1H), 6.85 (d, J ¼ 7.8 Hz, 1H), 6.75 (t, J ¼ 7.6 Hz,
1H), 6.59 (d, J ¼ 7.9 Hz, 1H). 13C NMR (150 MHz, DMSO‑d6)
d 165.72,
144.34, 139.30, 133.94, 133.16, 132.47, 131.22, 124.81, 124.62, 122.18,
120.30, 117.40, 113.62, 111.21. Anal. Calcd. For C16H9BrN2O: C, 59.10;
H, 2.79; N, 8.62. Found: C, 59.15; H, 2.77; N, 8.66.
4.2.12. (Z)-2-(2-chlorophenyl)-2-(2-oxoindolin-3-ylidene)
acetonitrile (3l)
4.2.18. (Z)-2-(2-oxoindolin-3-ylidene)-2-(4-(trifluoromethyl)
phenyl)acetonitrile (3r)10
Orange red solid; mp 191e193 ꢁC; 1H NMR (600 MHz, DMSO‑d6)
Orange red solid; mp 237e239 ꢁC; 1H NMR (600 MHz, DMSO‑d6)
11.00 (s, 1H), 7.97 (d, J ¼ 8.1 Hz, 2H), 7.88 (d, J ¼ 8.5 Hz, 2H), 7.29
d
11.03 (s, 1H), 7.74 (d, J ¼ 8.1 Hz, 1H), 7.69e7.62 (m, 2H), 7.57 (td,
J ¼ 7.5,1.2 Hz,1H), 7.28 (t, J ¼ 7.7 Hz,1H), 6.85 (d, J ¼ 7.8 Hz,1H), 6.70
d
(t, J ¼ 7.7 Hz, 1H), 6.04 (d, J ¼ 8.1 Hz, 1H). 13C NMR (150 MHz,
(td, J ¼ 7.7, 1.2 Hz, 1H), 6.85 (d, J ¼ 7.8 Hz, 1H), 6.73 (td, J ¼ 7.7, 1.0 Hz,
1H), 6.48 (d, J ¼ 7.7 Hz, 1H). 13C NMR (150 MHz, DMSO‑d6)
d
165.63,
DMSO‑d6)
d 165.36, 144.46, 140.81, 134.23, 132.82, 132.05, 131.43,
131.04, 130.98, 129.27, 124.81, 122.42, 120.23, 116.21, 111.31, 111.15.
Anal. Calcd. For C16H9ClN2O: C, 68.46; H, 3.23; N, 9.98. Found: C,
68.55; H, 3.21; N, 9.95.
144.51, 139.95, 137.39, 134.17, 131.19, 130.98, 130.17, 127.10 (q,
J ¼ 3.7 Hz), 125.15, 124.87, 123.34, 122.23, 120.13, 117.33, 113.08,
111.28. Anal. Calcd. For C17H9F3N2O: C, 64.97; H, 2.89; N, 8.91.
Found: C, 65.09; H, 2.87; N, 8.87.
4.2.13. (Z)-2-(3-chlorophenyl)-2-(2-oxoindolin-3-ylidene)
acetonitrile (3m)
4.2.19. (Z)-2-(2-oxoindolin-3-ylidene)-2-(thiophen-3-yl)
acetonitrile (3s)10
Orange red solid; mp 196e198 ꢁC; 1H NMR (600 MHz, DMSO‑d6)
Reddish brown solid; mp 179e181 ꢁC; 1H NMR (600 MHz,
d
10.97 (s, 1H), 7.74 (s, 1H), 7.66 (d, J ¼ 7.9 Hz,1H), 7.63e7.57 (m, 2H),
DMSO‑d6)
d
10.95 (s, 1H), 7.97 (dd, J ¼ 5.1, 1.2 Hz, 1H), 7.60 (dd,
7.28 (t, J ¼ 7.6 Hz, 1H), 6.84 (d, J ¼ 7.8 Hz, 1H), 6.73 (t, J ¼ 7.7 Hz, 1H),
J ¼ 3.6, 1.2 Hz, 1H), 7.31 (td, J ¼ 7.7, 1.2 Hz, 1H), 7.27 (dd, J ¼ 5.1,
3.6 Hz, 1H), 7.08 (d, J ¼ 8.0 Hz, 1H), 6.85 (d, J ¼ 7.8 Hz, 1H), 6.80 (td,
6.47 (d, J ¼ 7.7 Hz, 1H). 13C NMR (150 MHz, DMSO‑d6)
d 165.65,
144.43, 139.77, 135.20, 134.63, 134.00, 132.09, 130.96, 128.71, 127.76,
124.80, 122.14, 120.28, 117.33, 113.06, 111.25. Anal. Calcd. For
J ¼ 7.7, 1.1 Hz, 1H). 13C NMR (150 MHz, DMSO‑d6)
d 165.74, 144.31,
138.93, 134.17, 133.94, 131.97, 131.83, 128.98, 124.52, 122.09, 120.32,
117.20, 111.19, 108.07. Anal. Calcd. For C14H8N2OS: C, 66.65; H, 3.20;
N, 11.10. Found: C, 66.69; H, 3.19; N, 11.05.
C
16H9ClN2O: C, 68.46; H, 3.23; N, 9.98. Found: C, 68.38; H, 3.25; N,
10.02.
4.2.14. (Z)-2-(4-chlorophenyl)-2-(2-oxoindolin-3-ylidene)
acetonitrile (3n)
4.2.20. (Z)-2-(naphthalen-2-yl)-2-(2-oxoindolin-3-ylidene)
acetonitrile (3t)
Orange red solid; mp 256e258 ꢁC; 1H NMR (600 MHz, CDCl3)
Orange red solid; mp 210e212 ꢁC; 1H NMR (600 MHz, DMSO‑d6)
d
7.84 (s, 1H), 7.56 (d, J ¼ 8.6 Hz, 2H), 7.53 (d, J ¼ 8.5 Hz, 2H), 7.29 (t,
d
11.01 (s, 1H), 8.17 (d, J ¼ 8.3 Hz, 1H), 8.09 (d, J ¼ 8.2 Hz, 1H), 7.87 (d,
J ¼ 7.7 Hz, 1H), 6.89 (d, J ¼ 7.9 Hz, 1H), 6.87 (d, J ¼ 7.9 Hz, 1H), 6.78 (t,
J ¼ 8.4 Hz, 1H), 7.74 (dd, J ¼ 7.1, 1.2 Hz, 1H), 7.68 (dd, J ¼ 8.2, 7.1 Hz,
1H), 7.62 (ddd, J ¼ 8.0, 6.7, 1.2 Hz, 1H), 7.56 (ddd, J ¼ 8.2, 6.8, 1.3 Hz,
1H), 7.17 (td, J ¼ 7.7, 1.2 Hz, 1H), 6.82 (d, J ¼ 7.7 Hz, 1H), 6.45 (td,
J ¼ 7.7, 1.0 Hz, 1H), 5.74 (d, J ¼ 6.7 Hz, 1H). 13C NMR (150 MHz,
J ¼ 7.7 Hz, 1H). 13C NMR (150 MHz, DMSO‑d6)
d 165.71, 144.33,
139.37, 135.85, 133.92, 132.08, 131.04, 130.25, 124.82, 122.17, 120.30,
117.47, 113.56, 111.19. Anal. Calcd. For C16H9ClN2O: C, 68.46; H, 3.23;
N, 9.98. Found: C, 68.50; H, 3.21; N, 9.99.
DMSO‑d6)
d 165.59, 144.45, 141.11, 133.88, 133.70, 131.13, 130.19,
Please cite this article in press as: Xie D, Li Z, Synthesis of 2-(2-oxoindolin-3-ylidene)-2-arylacetonitriles through transition metal-free C(sp2)